Cargando…
Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNA
Blood circulating cell-free DNA (cfDNA) is becoming popular in the search of promising predictive and prognostic biomarkers. Among these biomarkers, cfDNA methylation markers have especially gained considerable attention. A significant challenge in the utilization of cfDNA methylation markers is the...
Autores principales: | Worm Ørntoft, Mai-Britt, Jensen, Sarah Østrup, Hansen, Thomas Birkballe, Bramsen, Jesper Bertram, Andersen, Claus Lindbjerg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687322/ https://www.ncbi.nlm.nih.gov/pubmed/28557629 http://dx.doi.org/10.1080/15592294.2017.1334024 |
Ejemplares similares
-
Age‐stratified reference intervals unlock the clinical potential of circulating cell‐free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer
por: Ørntoft, Mai‐Britt Worm, et al.
Publicado: (2020) -
Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study
por: Jensen, Sarah Østrup, et al.
Publicado: (2019) -
Re-Inspection of Small RNA Sequence Datasets Reveals Several Novel Human miRNA Genes
por: Hansen, Thomas Birkballe, et al.
Publicado: (2010) -
Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood
por: Kresse, Stine H., et al.
Publicado: (2023) -
Identifying Recurrences Among Non-Metastatic Colorectal Cancer Patients Using National Health Data Registries: Validation and Optimization of a Registry-Based Algorithm in a Modern Danish Cohort
por: Nors, Jesper, et al.
Publicado: (2023)